BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus
Fabien B Vincent, Eric F Morand, Fabienne Mackay
Immunology & Cell Biology | WILEY | Published : 2012
Eric F Morand has received travel sponsorship and a consultancy payment from GlaxoSmithKline (GSK). Fabien Vincent and Fabienne Mackay have no financial support or other benefits from commercial sources for the work reported in the paper, or any other financial interests, which could create a potential conflict of interest or the appearance of a conflict of interest with regard to the work.